Beijing Aosaikang Pharmaceutical Co Ltd Sustainability Reports
The company is primarily engaged in the research, development, production, and sales of active pharmaceutical ingredients and formulations. Its core therapeutic focuses encompass gastrointestinal, anti-tumor, anti-infection, and chronic disease treatments.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG006FYHH18
1 reports from 2023 to 2023
